BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

135 related articles for article (PubMed ID: 27172928)

  • 1. MicroRNA 141 Expression Is a Potential Prognostic Marker of Biliary Tract Cancers.
    Kim J; Ryu JK; Lee SH; Kim YT
    Gut Liver; 2016 Sep; 10(5):836-41. PubMed ID: 27172928
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Expression of the caudal-type homeodomain transcription factors CDX 1/2 and outcome in carcinomas of the ampulla of Vater.
    Hansel DE; Maitra A; Lin JW; Goggins M; Argani P; Yeo CJ; Piantadosi S; Leach SD; Biankin AV
    J Clin Oncol; 2005 Mar; 23(9):1811-8. PubMed ID: 15774774
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Comparison of Inflammation-based Prognostic Scores in Patients With Biliary Tract Cancer After Surgical Resection.
    Utsumi M; Kitada K; Tokunaga N; Yoshida Y; Narusaka T; Hamano R; Miyasou H; Tsunemitsu Y; Otsuka S; Inagaki M
    Anticancer Res; 2021 Apr; 41(4):2147-2155. PubMed ID: 33813426
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Amplification and overexpression of c-erbB-2, epidermal growth factor receptor, and c-met in biliary tract cancers.
    Nakazawa K; Dobashi Y; Suzuki S; Fujii H; Takeda Y; Ooi A
    J Pathol; 2005 Jul; 206(3):356-65. PubMed ID: 15892172
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Activation of telomerase and its diagnostic application in biopsy specimens from biliary tract neoplasms.
    Niiyama H; Mizumoto K; Kusumoto M; Ogawa T; Suehara N; Shimura H; Tanaka M
    Cancer; 1999 May; 85(10):2138-43. PubMed ID: 10326691
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Descriptive study of gallbladder, extrahepatic bile duct, and ampullary cancers in the United States, 1997-2002.
    Goodman MT; Yamamoto J
    Cancer Causes Control; 2007 May; 18(4):415-22. PubMed ID: 17264972
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Status of surgical treatment of biliary tract cancer.
    Ishihara S; Miyakawa S; Takada T; Takasaki K; Nimura Y; Tanaka M; Miyazaki M; Nagakawa T; Kayahara M; Horiguchi A
    Dig Surg; 2007; 24(2):131-6. PubMed ID: 17446708
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Expression of oncogene products HER2/Neu and Ras and fibrosis-related growth factors bFGF, TGF-beta, and PDGF in bile from biliary malignancies and inflammatory disorders.
    Su WC; Shiesh SC; Liu HS; Chen CY; Chow NH; Lin XZ
    Dig Dis Sci; 2001 Jul; 46(7):1387-92. PubMed ID: 11478488
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Distribution and pathological features of pancreatic, ampullary, biliary and duodenal cancers resected with pancreaticoduodenectomy.
    Chandrasegaram MD; Chiam SC; Chen JW; Khalid A; Mittinty ML; Neo EL; Tan CP; Dolan PM; Brooke-Smith ME; Kanhere H; Worthley CS
    World J Surg Oncol; 2015 Feb; 13():85. PubMed ID: 25890023
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A phase II study of uracil-tegafur plus doxorubicin and prognostic factors in patients with unresectable biliary tract cancer.
    Furuse J; Okusaka T; Ohkawa S; Nagase M; Funakoshi A; Boku N; Yamao K; Yamaguchi T; Sato T
    Cancer Chemother Pharmacol; 2009 Dec; 65(1):113-20. PubMed ID: 19404641
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Biliary tract cancer treatment: 5,584 results from the Biliary Tract Cancer Statistics Registry from 1998 to 2004 in Japan.
    Miyakawa S; Ishihara S; Horiguchi A; Takada T; Miyazaki M; Nagakawa T
    J Hepatobiliary Pancreat Surg; 2009; 16(1):1-7. PubMed ID: 19110652
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The expression of matrix metalloproteinases in intrahepatic cholangiocarcinoma, hilar (Klatskin tumor), middle and distal extrahepatic cholangiocarcinoma, gallbladder cancer, and ampullary carcinoma: role of matrix metalloproteinases in tumor progression and prognosis.
    Kirimlioğlu H; Türkmen I; Başsüllü N; Dirican A; Karadağ N; Kirimlioğlu V
    Turk J Gastroenterol; 2009 Mar; 20(1):41-7. PubMed ID: 19330734
    [TBL] [Abstract][Full Text] [Related]  

  • 13. MicroRNA markers for the diagnosis of pancreatic and biliary-tract cancers.
    Kojima M; Sudo H; Kawauchi J; Takizawa S; Kondou S; Nobumasa H; Ochiai A
    PLoS One; 2015; 10(2):e0118220. PubMed ID: 25706130
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Rising incidence of biliary tract cancers in Shanghai, China.
    Hsing AW; Gao YT; Devesa SS; Jin F; Fraumeni JF
    Int J Cancer; 1998 Jan; 75(3):368-70. PubMed ID: 9455795
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Biliary tract cancers in Cote-d'Or (France): incidence and natural history.
    Renard P; Boutron MC; Faivre J; Milan C; Bedenne L; Hillon P; Klepping C
    J Epidemiol Community Health; 1987 Dec; 41(4):344-8. PubMed ID: 3455429
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Elevated levels of neutrophil gelatinase-associated lipocalin in bile from patients with malignant pancreatobiliary disease.
    Zabron AA; Horneffer-van der Sluis VM; Wadsworth CA; Laird F; Gierula M; Thillainayagam AV; Vlavianos P; Westaby D; Taylor-Robinson SD; Edwards RJ; Khan SA
    Am J Gastroenterol; 2011 Sep; 106(9):1711-7. PubMed ID: 21670771
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Biliary bile acid concentration is a simple and reliable indicator for liver function after hepatobiliary resection for biliary cancer.
    Kurumiya Y; Nagino M; Nozawa K; Kamiya J; Uesaka K; Sano T; Yoshida S; Nimura Y
    Surgery; 2003 May; 133(5):512-20. PubMed ID: 12773979
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Biliary tract cancer treatment: results from the Biliary Tract Cancer Statistics Registry in Japan.
    Nagakawa T; Kayahara M; Ikeda S; Futakawa S; Kakita A; Kawarada H; Matsuno M; Takada T; Takasaki K; Tanimura H; Tashiro S; Yamaoka Y
    J Hepatobiliary Pancreat Surg; 2002; 9(5):569-75. PubMed ID: 12541042
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Polymorphisms of genes in the lipid metabolism pathway and risk of biliary tract cancers and stones: a population-based case-control study in Shanghai, China.
    Andreotti G; Chen J; Gao YT; Rashid A; Chen BE; Rosenberg P; Sakoda LC; Deng J; Shen MC; Wang BS; Han TQ; Zhang BH; Yeager M; Welch R; Chanock S; Fraumeni JF; Hsing AW
    Cancer Epidemiol Biomarkers Prev; 2008 Mar; 17(3):525-34. PubMed ID: 18296645
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Papillary carcinoma with diffuse papillomatosis of gallbladder and cystic duct.
    Kosemehmetoglu K; Akpinar E; Sokmensuer C; Hamaloglu E
    Ann Diagn Pathol; 2011 Apr; 15(2):140-4. PubMed ID: 20952295
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.